Tutorials
Landos Biopharma Inc logo

Landos Biopharma Inc

$ 1.06 -0.02 (-1.85%) 08:08 PM EST
P/E:
At Loss
P/B:
0.69
Market Cap:
$ 42.67M
Enterprise V:
$ -31.10M
Volume:
126.80K
Avg Vol (2M):
104.88K
Volume:
126.80K
Market Cap $:
42.67M
PE Ratio:
At Loss
Avg Vol (2-Month):
104.88K
Enterprise Value $:
-31.10M
PB Ratio:
0.69
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Landos Biopharma Inc
NAICS : 541714 SIC : 2833
1800 Kraft Drive, Suite 216, Blacksburg, VA, USA, 24060
Description
Landos Biopharma Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. It has several active development programs, each discovered internally, targeting novel pathways at the interface of immunity and metabolism. The LANCE platform identifies novel therapeutic targets based on predictions of immunometabolic function and creates therapeutic candidates to engage those targets in areas of unmet medical need.
Name Current Vs Industry Vs History
Cash-To-Debt 2733.19
Equity-to-Asset 0.8
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.97
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 48.09
9-Day RSI 54.82
14-Day RSI 56.46
6-1 Month Momentum % -60.69
12-1 Month Momentum % -94.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.99
Quick Ratio 4.99
Cash Ratio 4.76

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.3

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -243.72
Net Margin % -241.49
ROE % -49.5
ROA % -43.12
ROIC % -6118.55
ROC (Joel Greenblatt) % -8007.3
ROCE % -49.92

Financials (Next Earnings Date:2022-11-15 Est.)

LABP's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:LABP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 18
EPS (TTM) ($) -1.39
Beta 0
Volatility % 77.46
14-Day RSI 56.46
14-Day ATR ($) 0.125476
20-Day SMA ($) 0.9388
12-1 Month Momentum % -94.03
52-Week Range ($) 0.5501 - 16.17
Shares Outstanding (Mil) 40.25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Landos Biopharma Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More